Response to ASX Price Query

• No undisclosed information that could explain recent trading
• Confirming compliance with continuous disclosure obligations
• Providing background on company's lead drug candidates

Tissue Repair Ltd (ASX: TRP) has provided a response to an ASX price query regarding the recent trading in its securities. The company confirmed that it is not aware of any information concerning it that has not been announced to the market and which could explain the recent trading. TRP also confirmed that it is complying with its continuous disclosure obligations under the ASX Listing Rules. The company provided background on its lead drug candidates, including TR987® for chronic wounds and TR Pro+®, a topical treatment designed to accelerate healing and improve skin quality following cosmetic or medical procedures. TRP's proprietary Glucoprime® API underpins a growing pipeline of therapeutic solutions. The company's responses have been authorized and approved under its continuous disclosure policy.